⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PGEN News
Precigen, Inc. Common Stock
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Form 8-K
sec.gov
PGEN
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
accessnewswire.com
PGEN
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices
prnewswire.com
PGEN
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
prnewswire.com
PGEN
Sage Growth Partners Strengthens Digital Marketing Capabilities with Hiring of Raheim Bundle
prnewswire.com
GEHC
PGNY
NXPI
PGEN
PHG
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
prnewswire.com
PGEN
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
prnewswire.com
PGEN
Form 8-K
sec.gov
PGEN
Precigen Reports First Quarter 2026 Financial Results and Business Updates
prnewswire.com
PGEN